Latest Updates

Weathering the Economic Storm

With an unprecedented economic shutdown during the first half of 2020, many companies scrambled to adjust their business models and product lines to survive. Polysciences, Inc. and AVATAR shared their approach for overcoming business challenges and leveraging the opportunities that have unfolded throughout the year.

October 15, 2020

SOCMA’s Specialty Insights Highlights Industry’s Adaptability and Agility

The Society of Chemical Manufacturers & Affiliates (SOCMA) is pleased to announce the release of the third issue of the association’s semi-annual publication. Written and developed specifically for the specialty and fine chemical value chain, this edition, “Charting the Course for 2021,” showcases the journey of the industry during this unprecedented year.

October 8, 2020

Pilot Chemical Announces Leadership Transition

Pilot Chemical Corp., a privately owned and independent global specialty chemical company, announced today that Pamela Butcher will step down from her CEO role effective January 1, 2021. She will remain on the Pilot Board of Directors and serve as a special advisor to the Chairman.

October 5, 2020

Gelest Shareholders Close Sale to Mitsubishi Chemical | Jonathan Goff Appointed as Gelest Chief Technology Officer

Gelest announced today it has completed the sale of Gelest Intermediate Holdings to Mitsubishi Chemical America, Inc. (MCA; Head office: New York, the United States; President: Steve Yurich), the U.S. subsidiary of Mitsubishi Chemical Corporation (MCC; Head office: Chiyoda-ku, Tokyo; President: Masayuki Waga). Gelest Intermediate Holdings is the parent of Gelest, Inc. and Bimax, Inc. (Gelest; Head office: Pennsylvania, the United States; Chair: Barry Arkles, CEO: Ken Gayer). The transaction, which was announced on April 30, 2020, has cleared all regulatory approvals.

October 5, 2020

Pilot Chemical Adds EPA Emerging Viral Pathogen Claim to Eight Products

Pilot Chemical Corp. is pleased to announce that through its subsidiary Mason Chemical Company, it has received EPA acceptance to add an emerging viral pathogen claim to the labels of eight products from the company’s EPA-registered quaternary ammonium compound and active ingredient line, under its Maquat® and Maguard® brands.

October 1, 2020